96 related articles for article (PubMed ID: 15157044)
1. Loss of SMAD4 function in small intestinal adenocarcinomas: comparison of genetic and immunohistochemical findings.
Bläker H; Aulmann S; Helmchen B; Otto HF; Rieker RJ; Penzel R
Pathol Res Pract; 2004; 200(1):1-7. PubMed ID: 15157044
[TBL] [Abstract][Full Text] [Related]
2. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
[TBL] [Abstract][Full Text] [Related]
3. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study.
Svrcek M; Jourdan F; Sebbagh N; Couvelard A; Chatelain D; Mourra N; Olschwang S; Wendum D; Fléjou JF
J Clin Pathol; 2003 Dec; 56(12):898-903. PubMed ID: 14645346
[TBL] [Abstract][Full Text] [Related]
5. Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma.
Kim JY; Park DY; Kim GH; Choi KU; Lee CH; Huh GY; Sol MY; Song GA; Jeon TY; Kim DH; Sim MS
Histol Histopathol; 2005 Apr; 20(2):543-9. PubMed ID: 15736060
[TBL] [Abstract][Full Text] [Related]
6. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
7. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
Ando T; Sugai T; Habano W; Jiao YF; Suzuki K
J Gastroenterol; 2005 Jul; 40(7):708-15. PubMed ID: 16082587
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
10. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
11. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
12. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
13. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation.
Michel S; Kloor M; Singh S; Gdynia G; Roth W; von Knebel Doeberitz M; Schirmacher P; Bläker H
Mol Carcinog; 2010 Feb; 49(2):175-82. PubMed ID: 19852062
[TBL] [Abstract][Full Text] [Related]
14. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
15. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A
Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445
[TBL] [Abstract][Full Text] [Related]
16. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
Maitra A; Molberg K; Albores-Saavedra J; Lindberg G
Am J Pathol; 2000 Oct; 157(4):1105-11. PubMed ID: 11021814
[TBL] [Abstract][Full Text] [Related]
17. Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma.
Chan OT; Chen ZM; Chung F; Kawachi K; Phan DC; Himmelfarb E; Lin F; Perry A; Wang HL
Am J Clin Pathol; 2010 Dec; 134(6):880-5. PubMed ID: 21088150
[TBL] [Abstract][Full Text] [Related]
18. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku K; Miyoshi H; Matsunaga A; Oshima M; Sasaki N; Taketo MM
Cancer Res; 1999 Dec; 59(24):6113-7. PubMed ID: 10626800
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
20. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
